Prodromal Alzheimer's Disease

23 clinical trials · Condition

Record	Firm	Date
Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study (NCT04992975)	Nottingham University Hospitals NHS Trust	2021-09-10
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension (NCT04937959)	Novoic Limited	2021-01-22
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping (NCT04928976)	Novoic Limited	2021-01-22
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension (NCT04951284)	Novoic Limited	2021-01-21
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech (NCT04828122)	Novoic Limited	2020-11-19
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension (NCT04851496)	Novoic Limited	2020-11-19
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension (NCT04846426)	Novoic Limited	2020-11-19
The Digital Memory Notebook (NCT04240665)	University of California, Davis	2020-11-11
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease (NCT04029623)	Emory University	2019-10-29
TRC-PAD Program: In-Clinic Trial-Ready Cohort (NCT04004767)	University of Southern California	2019-06-04
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease (NCT03486938)	AgeneBio	2018-12-13
Deferiprone to Delay Dementia (The 3D Study) (NCT03234686)	Neuroscience Trials Australia	2018-01-19
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) (NCT02910739)	Merck Sharp & Dohme LLC	2016-10-11
Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (NCT01953601)	Merck Sharp & Dohme LLC	2013-11-05

Track Prodromal Alzheimer's Disease automatically

Every clearance here is in the API, with alerts when new ones post.